7-96121695-C-T
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM1PM2PP3_StrongPP5
The NM_014251.3(SLC25A13):c.1801G>A(p.Glu601Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000434 in 1,613,988 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_014251.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC25A13 | ENST00000265631.10 | c.1801G>A | p.Glu601Lys | missense_variant | 17/18 | 1 | NM_014251.3 | ENSP00000265631.6 | ||
SLC25A13 | ENST00000416240.6 | c.1804G>A | p.Glu602Lys | missense_variant | 17/18 | 1 | ENSP00000400101.2 | |||
SLC25A13 | ENST00000494085.1 | n.304G>A | non_coding_transcript_exon_variant | 1/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152108Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000410 AC: 6AN: 1461880Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 727240
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152108Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74296
ClinVar
Submissions by phenotype
Citrin deficiency Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 05, 2023 | This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 601 of the SLC25A13 protein (p.Glu601Lys). This variant is present in population databases (rs80338727, gnomAD 0.01%). This missense change has been observed in individuals with clinical features of citrin deficiency (PMID: 11793471, 14680984, 20927635). ClinVar contains an entry for this variant (Variation ID: 21512). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC25A13 protein function. Experimental studies have shown that this missense change affects SLC25A13 function (PMID: 23053473). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Citrullinemia, type II, adult-onset Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 16, 2024 | - - |
Neonatal intrahepatic cholestasis due to citrin deficiency;CN295299:Citrullinemia, type II, adult-onset Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 22, 2024 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | May 21, 2024 | Variant summary: SLC25A13 c.1801G>A (p.Glu601Lys) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251090 control chromosomes. c.1801G>A has been reported in the literature in the singly heterozygous or presumed compound heterozygous state in multiple individuals affected with Citrullinemia Type II (example, Kobayashi_2003, Chen_2013, Saheki_2002, Yamaguchi_2002, Fu_2011). These data indicate that the variant may be associated with disease. Functional analysis found that a yeast strain lacking the corresponding gene could not grow when this variant was introduced during complementation analysis, suggesting a lethal metabolic defect in this model system; protein levels were not impacted when strains were grown with adequate supplementation (example, Wongkittichote_2013). In patient cells presumed compound heterozygous with p.Leu85Pro protein levels were undetectable (example, Fu_2011) however the mechanism of protein loss/instability was not explored. The following publications have been ascertained in the context of this evaluation (PMID: 23901231, 20927635, 14680984, 12111366, 23053473, 11793471). ClinVar contains an entry for this variant (Variation ID: 21512). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. - |
Neonatal intrahepatic cholestasis due to citrin deficiency Other:1
not provided, no classification provided | literature only | GeneReviews | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at